Skip to search.
 STI Down0.49%

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS

6.33 Down 0.05(0.78%) 04:00 SGT|After Hours : 6.33 0.00 (0.00%) 04:32 SGT

Add to Portfolio
Company EventsGet Company Events for:
Upcoming Events 
DateEvent
7-Aug-13Earnings announcement
Recent Events 
DateEvent
7-Jun-13OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a
9-May-13OREXIGEN THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report
8-May-13Orexigen Therapeutics, Inc. Earnings Call scheduled for 5:00 pm ET today
8-May-13OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
14-Mar-13OREXIGEN THERAPEUTICS, INC. Files SEC form 10-K, Annual Report
13-Mar-13Orexigen Therapeutics, Inc. Earnings Call scheduled for 5:00 pm ET today
13-Mar-13OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
20-Feb-13OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Pr
30-Nov-12OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
9-Nov-12OREXIGEN THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report
7-Nov-12OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
25-Oct-12OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Financial Statements and Exhibits
24-Oct-12OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition
22-Oct-12OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Other Events
20-Sep-12OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
5-Sep-12OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhi
9-Aug-12OREXIGEN THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report
7-Aug-12OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
11-Jul-12OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Other Events
11-Jun-12OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
6-Jun-12OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Other Events